The key is based on identifying particular proteins in these cells.

The key is based on identifying particular proteins in these cells, which make them sensitive to specific drugs particularly for fat burning . The researchers, from the Circulating Tumour Cells and Metastasis research group of GENYO have obtained an award at the 9th International Symposium on Minimal Residual Malignancy, held in Paris recently, for their study into the usage of CTCs and particular markers in these cells, as a clinical device to look for the response to remedies administered to patients with advanced colon cancer. Related StoriesChemotherapy treatment can contribute to long-term neurocognitive deficits in pediatric mind tumor survivorsMultigene check performed on tumor can identify breast cancer individuals who can securely avoid chemotherapyVA Medical center performs first successful heated chemotherapy bath on a patient with mesothelioma The individuals, studied in the Oncology Device of the Clinical Medical center of Granada and the Hospital of Motril, underwent a typical treatment in this illness, which include chemotherapy and a specific monoclonal antibody that decreases the vascularization of the tumour.